THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-gamma SECRETING ALLOGENEIC TUMORVACCINE
Dokumenttyp:
Meeting Abstract
Autor(en):
Kuebler, HR; Brill, T; van Randenborgh, H; Paul, R; Fend, F; Pohla, H; Schendel, DJ; Hartung, R; Gansbacher, B